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Abstract
The article presents a review of current medical and psychological literature published between 2000 - 2010, with the use of 
the PubMed database, concerning the occurrence of anxiety and depression in diabetic patients, with particular consideration 
of those aff ected by complications. Anxiety and fear are the most frequent emotional disorders among diabetic patients. 
Depression occurs in approximately 30% of patients with diabetes. Both diabetes and depression belong to so called ‘life 
style’ or ‘civilization diseases’. Numerous studies have confi rmed that the course of depression in patients with diabetes is 
more severe, and the relapses of depression episodes are more frequent. The studies show that diabetic patients experience 
various types of psychosocial and emotional problems due to which the monitoring of own state of health is not the priority 
in life. In the process of treatment of both sole diabetes and concomitant anxiety and depression it is important to adjust 
and motivate patients to apply widely understood therapeutic recommendations. The treatment of depression syndrome 
in the course of diabetes does not have to lead to improvement in glycaemic control. The following factors infl uencing 
the therapeutic eff ect should be mentioned: duration of diabetes, presence of complications, and the eff ect of the drugs 
applied on body weight, or possibly initial diabetes management. It seems, therefore, that the patient education model 
based on the provision of knowledge concerning diabetes and its complications, methods of treatment, principles of 
nutrition and health-promoting life style, may be insuffi  cient, at least for patients with depression. The results of a review 
of reports shows that an optimum treatment of diabetes, in accordance with the current state of knowledge, requires from 
physicians a special consideration of psychological and psychiatric knowledge for the 2 following reasons: 1) eff ectiveness 
of therapy to a high degree depends on the proper behaviour of a patient; 2) considerably more frequent, compared to the 
total population, occurrence of the symptoms of emotional disorders negatively aff ect the course of diabetes.
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INTRODUCTION AND OBJECTIVE
Anxiety and fear are the most frequent emotional disorders 
among diabetic patients, which has been confi rmed by 
the results of many studies [1-3]. Depression occurs in 
approximately 30% of patients with type 1 and type 2 diabetes 
[4]. Both diabetes and depression belong to so called ‘life 
style’ or ‘civilization diseases’[5] and their development may 
depend on life-style – in the case of type 2 diabetes in females 
[6]. Depressive symptoms are among the major contributors 
to non–successive aging by the infl uence on both mental and 
physical health [7]. 
Depression may lead to an unhealthy life style among 
patients with high risk of coronary heart disease [8] and 
the life-style may be one of the major factors contributing to 
life span [9]. Additionally, good health perception and well-
being exert an eff ect on the mortality ratio [10]. Numerous 
studies have confi rmed that the course of depression in 
patients with diabetes is more severe, and the relapses of 
depression episodes are more frequent, especially in patients 
with unbalanced diabetes. Data from the National Heath 
and Nutrition Examination Survey indicate that attaining 
good diabetes control is possible in only approximately 40% 
of patients, whereas as many as 20% have HbA1c ≥ 9%, i.e., 
exceeding the most liberal levels accepted for patients [11]. 
It seems, therefore, that the patient education model 
based on the provision of knowledge concerning diabetes 
and its complications, methods of treatment, principles of 
nutrition and health-promoting life style, may be insuffi  cient, 
at least for some patients. In the newest ADA Standards of 
Medical Care in Diabetes 2011 – Psychosocial assessments 
and care [12] was rated as E – as ‘Expert opinion’, which 
means that ‘there is as yet no evidence from clinical trials, 
or in which there is confl icting evidence’ [13]. On the other 
hand, Diabetes Self-Management Education (DSME) in the 
same recommendation was rated between B (need of self-
management education).
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Th is allows the presumption that understanding the 
necessity for systemic care of a diabetic patient, also from 
the emotional and social aspects, to-date ADA has not found 
suffi  cient scientifi c evidence. Th e 2011 framework educational 
project discussed in the recommendations by the Polish 
Diabetic Association is complex, but suffi  cient for patients 
in a normal emotional and psychical state. However, in the 
case of depression syndrome accompanying diabetes, it may 
not be possible to perform this programme. [14]. 
Th e studies show that diabetic patients experience various 
types of psychosocial and emotional problems due to which 
the monitoring of own state of health is not the priority in 
life [15,16].
According to the assessments by researchers, 1 in 8 diabetic 
patients suff ers from fully symptomatic depression [16-17], 
whereas as many as 1 in 5 of the remaining patients show 
symptoms of depression [16]. 
An adequate glycemic control contributes to psychical and 
physical well-being. Social support, which may alleviate the 
depression symptoms in these patients, is also extremely 
important. In the situation of facing a disease, an individual 
may undertake various strategies, i.e. those which may lead 
to acceptance of the illness and cooperation with a physician, 
and strategies which may lead to auto-destruction and lack 
of a positive relationship with the physician. Th e selected 
model of behaviour may depend, among other things, on 
the patient’s emotional status. 
Th e article presents a review of current literature concerning 
the occurrence of anxiety and depression in diabetic 
patients, with particular consideration of those aff ected by 
complications. Medical and psychological literature was 
analyzed with the use of the PubMed database, from the 
aspect of reports containing the key words diabetes or diabetes 
mellitus, complications of diabetes mellitus and depression, 
published between 2000 - 2010, available in English. Th e 
studies carried out on an underage population and concerning 
diabetes during pregnancy were excluded. Due to the large 
number of reports which fulfi lled the above-mentioned 
criteria, the articles were selected which comprehensively 
describe the scope of problems of interest. 
State of knowledge. Studies concerning the treatment 
of diabetic patients with anti-depressants confi rmed 
a correlation between good general well-being and an 
improvement of glycemia control [18,19]. Th e results were 
obtained during cognitive-behavioural therapy in the case 
of patients with type 2 diabetes, and are diffi  cult to interpret 
unequivocally [20].
Considering the presence of the relationship between 
depression symptoms and hyperglycemia, and the 
relationship between hyperglycemia and the development 
of complications, it may be concluded that the presence 
of depression is correlated with the risk of the occurrence 
of complications [21]. Effi  cient treatment of depression 
in diabetic patients with concomitant depression may 
prevent or delay the development of vascular complications 
of this disease[22]. Th erefore, in the context of diabetes 
complications, an adequate psychiatric treatment is 
indispensable. Untreated depression may lead to negative and 
harmful behaviours concerning life-style (avoiding physical 
eff ort) [23], emotional overeating [24] including night-eating 
syndrome [25] and cigarette smoking [24]. Th is also leads to 
nutritional disorders – psychological anorexia and bulimia, 
especially in female patients with type 1 diabetes [26]. Last, 
but not least, it leads to poor self-care and self-management 
and treatment adherence [23,24]. 
Depressive disorders may precede the development 
of diabetes, although their relationship has not been 
unequivocally confi rmed [27], and may also concern the 
negative eff ect of depression on a patient’s life-style [23-25]. 
Depressive disorders concomitant with diabetes are correlated 
with a higher risk of the occurrence of complications, 
macro- and micro-vascular, both in type 1 and 2 diabetes 
[5,12,21,25,26,28-30] as in, e.g. De Groot who performed 
meta-analysis based on studies concerning type 1 and 2 
diabetes during the period 1975-1999 [21]. In the Fremantle 
Study, the group of diabetic patients examined exceeded 
1,400 individuals aged over 7 [28]. Despite this, it was not 
confi rmed that depression was an independent predictor of 
total mortality or mortality due to cardiovascular diseases 
[28].
Th ere is a relationship between the presence of depression 
in diabetic patients and deterioration of glycaemia [30] and 
between depression and some neurohormonal changes, 
including increase in counterregulatory hormones (cortisol, 
catecholamines, growth hormone) which may lead to insulin 
resistance and impaired B cell function – the fundamental 
changes for type 2 diabetes [31]. 
On the other hand, it seems that there is no way of reversal 
– the eff ective treatment of depression (reduction of scores in 
depression scales of Becks and Hamilton) does not improve 
fasting glycaemia nor the level of HbA1c during one year of 
observation [32].
Depression which fulfi lls the criteria of a severe episode 
is an independent risk factor of the development of IHD 
in females with diabetes [33]. Th e relationship between the 
presence of depression and the development of subclinical 
atherosclerosis of the carotid arteries concerns exclusively 
males with type 1 diabetes [30].
Th e episode of severe depression increases the risk of death 
almost 3-fold due to diabetes related uraemia, compared 
to patients without depression, or with mild or moderate 
intensity of symptoms diagnosed [34]. In addition, a faster 
progression of diabetic retinopathy was observed in patients 
with type 1 diabetes, and those obtaining high depression 
indices according to the Beck’s scale [35]. A correlation 
was confi rmed between the occurrence of neuropathy and 
presence of depression symptoms in diabetes [36], and it 
was also found that diabetes complicated by polyneuropathy 
correlates with worse glycemia control and a higher risk of 
anxiety and depressive disorders [37]. 
Patients with diabetes complications report primarily 
the deterioration of the quality of life caused by emotional 
disorders [38-41]. In about a half of diabetic patients 
hospitalized due to cardiovascular diseases, concomitant 
depressive and anxiety symptoms were also noted 
[38,42,43]. 
A group of risk factors was specifi ed which directly result 
in the occurrence of a severe depression episode in the course 
of diabetes, including past depressive episode, degree of 
intensity of symptoms of diabetes, and past cardiovascular 
surgeries [44]. It was estimated that the presence of depression 
in patients with diabetes increases the costs of treatment 
by 50-75% [45]. A correlation was also confi rmed between 
depression in diabetes and cognitive functions disorders 
[46]. Th e studies show that the episode of severe depression 
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with less balanced diabetes control [58,59,65]. Conclusions 
drawn based on meta-analysis carried out among the Chinese 
population indicate that depression occurs twice as oft en in 
diabetic patients than in the total population [65]. 
It is noteworthy that the risk of complications is increased 
for patients with both type 1 and 2 diabetes, despite the 
diff erences in etiology between these two diseases. Th e 
common background seems to be an increase in the severity 
of the disease or the number of complications [21], as well as 
the method of treatment. Patients treated with insulin, with 
poor glycaemic control, seem to be at risk of deterioration of 
depressive symptoms, unlike those taking oral hypoglycaemic 
agents [66].
Pharmacological treatment of depression among diabetic 
patients has mixed outcomes. Th ere is strong evidence that 
depression has a signifi cant impact on diabetic disability 
– even 7 times more (unemployment, lack of social activities), 
compared to patients with one isolated condition (diabetes 
or depression) [67], and that in low income communities 
pharmacological treatment of depression improved the level 
of HbA1c [68].
On the other hand, there is evidence that the connection 
between diabetes and depression worsens the eff ects of 
antidepressant therapy, especially among patients with pain 
[69]. Th e observed lack of reduction in the events of disorders 
in carbohydrate metabolism or improvement of glycemia as 
a result of treatment with antidepressants may be associated 
with weight gain and the development of obesity [70], or the 
negative impact on behavioural factors [13-16, 71].
It was confi rmed that the treatment of depression lasting 
for a year results in a considerable improvement (a decrease 
on the Beck and Hamilton scale); however, it is not converted 
into the improvement of glycemia, understood neither as 
the fasting blood glucose nor the HbA1c level. It should 
be mentioned that the initial HbA1c level was relatively 
low (7.6%) [32]. Th e study by Lustman, conducted in the 
90s, showed that a higher initial HbA1c level (10.3%) was 
accompanied by an improvement in glycaemic patients [20]. 
Th e results of selected studies also indicate that there is a 
strong relationship between glycaemia control and the level 
of depression among patients with type 1 diabetes [72-74].
With two or more diabetes complications and concomitant 
depression care based on the cooperation of many specialists 
is more eff ective in the reduction of depression symptoms 
than primary health care [75]. Such common medical care is 
even more important. According to the studies by Northam, 
adolescents aged 12 - aft er making the diagnosis of diabetes, 
despite their well-being as good as that of the control group 
– more rarely completed their schooling (by 17%), and more 
oft en required psychiatric assistance (19%) [76]. 
SUMMARY
Anxiety and depression are the most frequent emotional 
disorders occurring in diabetes. At present, it is known 
that the relationship between diabetes and depression is 
higher than that between diabetes and other psychiatric 
disorders.
Th e presence of a chronic disease (or a number of diseases) 
intensifi es the risk of the occurrence of depressive and anxiety 
disorders, which may additionally deteriorate the state of a 
patient by exerting a negative eff ect on his/her willingness 
accompanying diabetes increases the risk of the development 
of dementia [47]. 
Compared to the healthy individuals who participated 
in the study, adults with type 1 diabetes reported more 
symptoms of depression and a greater use of antidepressants 
[48]. Th e percentage of mental disorders, including anxiety 
and depression, observed in the population of young adults 
with type 1 diabetes is estimated at two or three times higher 
than in the population of their healthy contemporaries 
[49]. Fear of development of late complications of diabetes 
accompanied a considerable group of adolescents. According 
to a comparative report, 20% of diabetic patients showed 
symptoms of anxiety, whereas among healthy individuals 
this percentage was 8% [50]. 
In the relevant literature, two diabetes-related types of 
anxiety were also distinguished: fear of hypoglycemia and 
fear of late complications [49, 51-52]. 
A patient’s fear of hypoglycemia is frequently encountered 
by the clinicians. Th is emotional status may lead to intentional 
or unintentional activities by the patients, aimed at the 
elevation of the level of blood glucose in order to ‘protect 
oneself ’ against hypoglycemia [53]. In addition, the process 
itself, by exerting an eff ect on the autonomic system, e.g. 
induction of hunger, but also heart palpitations or feeling of 
anxiety, may lead to the deterioration of metabolic control 
and reinforcement of anxiety, or lead to a phobia [54]. Th is 
occurs especially in type 1 diabetes, in which hypoglycemia 
may be a fatal event, also due to the induction of heart rhythm 
disorders, [55]. In a case of type 2 diabetes the amount of 
hypoglycemia increases due to duration of the disease (over 
5 years) and with the administration of insulin [56]. As a 
result, diabetes may lead to the occurrence of decreased life 
satisfaction, low level of social activity, deterioration of the 
cognitive functions, and induce sleep disorders [57].
Studies of the Turkish population show that depression and 
anxiety constitute approximately 45% of psychiatric disorders 
in diabetic patients [58]. Nearly 79% of respondents in the 
presented survey experience anxiety related to diabetes. In 
patients with type 1 diabetes the level of anxiety was higher 
than in those with type 2 diabetes, due to the troublesome 
life mode in diabetic patients taking insulin [59]. 
Tuncay noted that males showed a higher level of anxiety 
than females, respondents with a higher level of education 
demonstrated a higher level of anxiety than those with a 
lower level of education, and patients who had a higher 
monthly salary were characterized by a higher level of 
anxiety, compared to those with a lower income [58]. An 
additional source of anxiety for patients may be knowledge 
of the eff ect of various hypoglycemizing therapies on an 
increase in the number of cancerous diseases, as well as the 
eff ect of diabetes and hyperglycemia per se on mortality due 
to cancerous diseases [60-62]. Th e total impact of cancer-
related fear among diabetic patients is not known; however, 
in a similar evaluation carried out among patient’s parents, 
the level of cancer-related distress signifi cantly exceeded the 
level of distress connected with diabetes [63]. 
In studies conducted in Croatia, a clinical form of 
depression was diagnosed in 33% of patients with diabetes [50]. 
According to Pouwer, 10-20% of patients with type 2 diabetes 
had depression; nevertheless, it was frequently undiagnosed 
[64]. In many studies it was noted that in diabetic patients 
the course of depression is more severe, and the relapses of 
depressive episodes more frequent, especially among those 
321Annals of Agricultural and Environmental Medicine 2011, Vol 18, No 2
Piotr Dziemidok, Marta Makara-Studzińska, Mirosław A. Jarosz. Diabetes and depression: a combination of civilization and life-style diseases is more than simple…
for treatment, cooperation with a physician, or even make 
self-control impossible. 
In the process of treatment of both sole diabetes and 
concomitant anxiety and depression it is important to adjust 
and motivate patients to apply widely understood therapeutic 
recommendations.
Th e treatment of depression syndrome in the course of 
a chronic disease such as diabetes does not have to lead to 
improvement in glycaemic control. Th e following factors 
infl uencing the therapeutic eff ect should be mentioned: 
duration of diabetes, presence of complications, and the 
eff ect of the drugs applied on body weight, or possibly initial 
diabetes management. 
Th e results of a review of reports for the years 2000-2010 
shows that an optimum treatment of diabetes, in accordance 
with the current state of knowledge, requires from physicians 
a special consideration of psychological and psychiatric 
knowledge for the following reasons: 
– eff ectiveness of therapy to a high degree depends on 
the proper behaviour of a patient, especially constant 
independent observance of a doctor’s orders; 
– considerably more frequent, compared to the total 
population, occurrence of the symptoms of emotional 
disorders, which are not only the source of problems in 
social functioning, but also negatively aff ect the course of 
diabetes. 
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